22nd Oct 2018 10:58
LONDON (Alliance News) - Feedback PLC on Monday said unit Feedback Medical Ltd has secured a number of orders for image texture analysis technology TexRAD.
The orders were secured from university hospitals across Europe, with first-time orders coming from Belgium and Portugal.
TexRAD can be used for aneurysms and carotid imaging of Crohn's disease and routinely acquired standard computed tomography and magnetic resonance images of liver cancer.
Feedback said it intends to expand its existing customer bases in the US and Asia. It has initiated plans for regulatory approval of TexRAD with the US Food & Drug Administration for use of TexRAD in clinical trials of drug candidates for marketing approval.
"These recent orders of TexRAD are further validation of Feedback Medical and our technology. We are taking advantage of our growing reputation to drive new business," said Balaji Ganeshan, global business development director of Feedback Medical.
"TexRAD is now being used in a diverse range of research fields which demonstrates the significant potential and applicability of our technology," added Ganeshan.
Feedback shares were trading 4.4% lower on Monday at 1.72 pence each.
Related Shares:
Feedback